Related Experiment Video

Updated: Jul 25, 2026

Live Imaging of Antifungal Activity by Human Primary Neutrophils and Monocytes in Response to A. fumigatus
12:29

Live Imaging of Antifungal Activity by Human Primary Neutrophils and Monocytes in Response to A. fumigatus

Published on: April 19, 2017

Management of fungal infection in neutropenic patients with fluconazole

K W Brammer1

  • 1Clinical Research Department, Pfizer Central Research, Sandwich, Kent, UK.

Haematology and Blood Transfusion
|January 1, 1990
PubMed

Insights

Fluconazole prophylaxis significantly reduced suspected fungal infections in neutropenic patients compared to oral polyenes. This new antifungal azole offers a promising approach for managing fungal infections in immunocompromised individuals.

Area of Science:

  • Mycology
  • Clinical Pharmacology
  • Hematology

Background:

  • Fungal infections pose a significant risk to neutropenic patients undergoing chemotherapy or bone marrow transplantation.
  • Existing prophylactic treatments with oral polyenes have limitations.
  • Fluconazole, an orally absorbed antifungal azole, demonstrates favorable efficacy and safety profiles.

Purpose of the Study:

  • To evaluate the prophylactic efficacy of oral fluconazole in neutropenic patients.
  • To compare fluconazole with established oral polyene regimens for fungal infection prevention.

Main Methods:

  • A multicenter, comparative clinical study involving 248 neutropenic patients with acute leukaemia, lymphoma, or aplastic anaemia.
  • Patients received either 50 mg daily oral fluconazole or standard oral polyene regimens.
  • Incidence of suspected and confirmed fungal infections was monitored.

Main Results:

  • The incidence of suspected fungal infections was significantly lower in the fluconazole group (27%) compared to the polyene group (45%) (P < 0.05).
  • Mycologically confirmed infections were markedly reduced, with only one case in the fluconazole group versus 17 in the polyene group.
  • Fluconazole prophylaxis was well tolerated by patients.

Conclusions:

  • Oral fluconazole is a promising prophylactic agent for preventing fungal infections in neutropenic patients.
  • Fluconazole demonstrates superior efficacy and tolerability compared to oral polyenes in this patient population.
  • Further research is needed to determine optimal dosing for fluconazole prophylaxis in neutropenic settings.

More Related Videos

Bio-energetics Investigation of Candida albicans Using Real-time Extracellular Flux Analysis08:48

Bio-energetics Investigation of Candida albicans Using Real-time Extracellular Flux Analysis

Published on: March 19, 2019

An Ex vivo Assay to Study Candida albicans Hyphal Morphogenesis in the Gastrointestinal Tract07:42

An Ex vivo Assay to Study Candida albicans Hyphal Morphogenesis in the Gastrointestinal Tract

Published on: July 1, 2020

Related Concept Videos

Cystic Fibrosis: Management01:24

Cystic Fibrosis: Management

Cystic fibrosis (CF) is an autosomal recessive disorder that predominantly affects individuals of Northern European descent, occurring at a rate of 1 in 3500. It is caused by a genetic mutation in a gene on chromosome 7, most commonly the ΔF508 mutation, that codes for the cystic fibrosis transmembrane conductance regulator (CFTR) protein. This results in thicker mucus secretions and obstruction pathologies in multiple organs, including the lungs and sinuses.
Sinus disease and chronic sinusitis...
Pneumonia IV: Management01:28

Pneumonia IV: Management

The treatment of pneumonia varies based on its severity and the causative pathogen. Here is a structured approach to managing pneumonia, integrating pharmaceutical and supportive care strategies.
Bacterial Pneumonia Treatment
For bacterial pneumonia, antibiotics serve as the cornerstone of therapy. Initial treatment often begins with empirical antibiotics, tailored to the anticipated causative organism and adjusted based on culture results. Key antibiotic choices include:
Fungal Phylum Microsporidia01:28

Fungal Phylum Microsporidia

Microsporidia are a group of obligate intracellular fungi that were initially classified as protists but were later reclassified based on phylogenetic, molecular, and structural evidence linking them to the Chytridiomycota. These unicellular, non-motile organisms are highly specialized parasites that infect a wide range of animal hosts, including humans. They have evolved extensive genomic and metabolic reductions, making them highly dependent on their hosts for survival.Morphology and Genomic...
Cryptococcal Meningitis01:27

Cryptococcal Meningitis

Cryptococcal meningitis is a life-threatening opportunistic infection predominantly associated with HIV/AIDS, accounting for over 100,000 deaths annually worldwide. However, it also affects individuals with other forms of immunosuppression, including those undergoing immunosuppressive therapy, organ transplant recipients, patients with innate immunodeficiencies, and individuals with hematological disorders. The infection is caused mainly by Cryptococcus neoformans and Cryptococcus gattii,...
Candidiasis01:20

Candidiasis

Candidiasis is a fungal infection caused by opportunistic species of Candida. It can affect various anatomical sites, including the skin, oral cavity, nails, and genitourinary tract. Among its forms, vaginal candidiasis is the most common type of mucosal infection. It typically results from the overgrowth of Candida albicans in the vaginal mucosa. Under normal conditions, C. albicans exists as a commensal organism within the vaginal microbiota, regulated by the dominance of lactobacilli, which...
Antifungal Agents01:15

Antifungal Agents

Amphotericin B is a broad-spectrum antifungal agent that exploits structural differences between fungal and mammalian cell membranes. Its amphipathic structure—featuring a hydrophobic polyene-lactone ring and a hydrophilic region containing mycosamine and carboxylic acid groups—enables selective binding to ergosterol, a sterol predominantly found in fungal plasma membranes. This selective interaction underlies the drug’s antifungal activity, although weak binding to cholesterol contributes to...